Advertisement

Care for the Postoperative Cardiac Surgery Patient

  • Andrew S. Kaufman
  • Philip S. Mullenix
  • Jared L. Antevil
Chapter

Abstract

The care for patients after cardiac surgery should begin with standardized pathways, with the goal of structured care criteria rooted in best available evidence. Such pathways are only a starting place, however, as every patient’s procedure and course is unique. Optimal care relies on a team that is able to recognize deviations from normal physiology and recovery in the context of a given condition and procedure and that institutes early and appropriate action when faced with potential complications.

In this chapter, a review of general management principles and techniques relevant to the care of cardiac surgical patients will be followed by guidance for the management of more specific clinical scenarios. Finally, this chapter will present some considerations unique to particular cardiac surgical procedures.

Keywords

Heart diseases [C14.280] Postoperative care [E02.760.731.700] Cardiac surgical procedures [E04.100.376] Cardiovascular physiological phenomena [G09.330] Heart valve diseases [C14.280.484] Coronary artery disease [C14.280.647.250.260] 

References

  1. 1.
    Cohn LH, Rosborough D, Fernandez J. Reducing costs and length of stay and improving efficiency and quality of care in cardiac surgery. Ann Thorac Surg. 1997;64(6 Suppl):S58–60. discussion S80-2PubMedCrossRefGoogle Scholar
  2. 2.
    Xu F, et al. Use of pulmonary artery catheter in coronary artery bypass graft. Costs and long-term outcomes. PLoS One. 2015;10(2):e0117610.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Whitener S, Konoske R, Mark JB. Pulmonary artery catheter. Best Pract Res Clin Anaesthesiol. 2014;28(4):323–35.PubMedCrossRefGoogle Scholar
  4. 4.
    St Andre AC, DelRossi A. Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med. 2005;33(9):2082–93.PubMedCrossRefGoogle Scholar
  5. 5.
    Baele PL, et al. Continuous monitoring of mixed venous oxygen saturation in critically ill patients. Anesth Analg. 1982;61(6):513–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013;41(7):1774–81.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Reddy PS, et al. Cardiac tamponade: hemodynamic observations in man. Circulation. 1978;58(2):265–72.PubMedCrossRefGoogle Scholar
  8. 8.
    Stern DH, et al. Can we trust the direct radial artery pressure immediately following cardiopulmonary bypass? Anesthesiology. 1985;62(5):557–61.PubMedCrossRefGoogle Scholar
  9. 9.
    Pauca AL, et al. Radial artery-to-aorta pressure difference after discontinuation of cardiopulmonary bypass. Anesthesiology. 1989;70(6):935–41.PubMedCrossRefGoogle Scholar
  10. 10.
    Gravlee GP, et al. A comparison of radial, brachial, and aortic pressures after cardiopulmonary bypass. J Cardiothorac Anesth. 1989;3(1):20–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003;17(5):576–84.PubMedCrossRefGoogle Scholar
  12. 12.
    Ketorolac Medication Guide, R.L. Inc, Editor. Nutley, 2008. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf
  13. 13.
    Oliveri L, Jerzewski K, Kulik A. Black box warning: is ketorolac safe for use after cardiac surgery? J Cardiothorac Vasc Anesth. 2014;28(2):274–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Wong WT, et al. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev. 2016;9:Cd003587.PubMedGoogle Scholar
  15. 15.
    Rafiq S, et al. Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial. J Cardiothorac Surg. 2014;9:52.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Ucak A, et al. The effects of gabapentin on acute and chronic postoperative pain after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2011;25(5):824–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Rodrigues RR, et al. Computed tomography assessment of lung structure in patients undergoing cardiac surgery with cardiopulmonary bypass. Braz J Med Biol Res. 2011;44(6):598–605.PubMedCrossRefGoogle Scholar
  18. 18.
    Garcia-Delgado M, Navarrete-Sanchez I, Colmenero M. Preventing and managing perioperative pulmonary complications following cardiac surgery. Curr Opin Anaesthesiol. 2014;27(2):146–52.PubMedCrossRefGoogle Scholar
  19. 19.
    Haverich A. Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. J Thorac Cardiovasc Surg. 2003;123(5):1361–6.Google Scholar
  20. 20.
    O’Shaughnessy K. Adrenergic mechanisms and drugs. In: Clinical pharmacology. Edinburgh: Elsevier; 2012. p. 382–92.CrossRefGoogle Scholar
  21. 21.
    Morales DL, et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003;75(3):926–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Leyh RG, et al. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg. 2003;125(6):1426–31.PubMedCrossRefGoogle Scholar
  23. 23.
    Cotton BA, et al. Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients. Arch Surg. 2008;143(1):62–7. discussion 67PubMedCrossRefGoogle Scholar
  24. 24.
  25. 25.
    Ho KM, Bham E, Pavey W. Incidence of venous thromboembolism and benefits and risks of Thromboprophylaxis after cardiac surgery: a systematic review and meta-analysis. J Am Heart Assoc. 2015;4(10):e002652.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Dunning J, et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg. 2008;34(1):73–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Mathew JG, et al. Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement. Thromb Haemost. 2014;112(6):1120–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Passaglia LG, de Barros GM, de Sousa MR. Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysis. J Thromb Haemost. 2015;13(9):1557–67.PubMedCrossRefGoogle Scholar
  29. 29.
    Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977–87.PubMedCrossRefGoogle Scholar
  30. 30.
    Mariscalco G, et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg. 2007;84(4):1158–64.PubMedCrossRefGoogle Scholar
  31. 31.
    Ozguler IM, et al. Rosuvastatin lowers systemic inflammatory response in coronary artery bypass graft accompanied by cardiopulmonary bypass surgery: a randomized controlled study. Clin Invest Med. 2015;38(4):E154–63.PubMedCrossRefGoogle Scholar
  32. 32.
    Zheng Z, et al. Perioperative Rosuvastatin in cardiac surgery. N Engl J Med. 2016;374(18):1744–53.PubMedCrossRefGoogle Scholar
  33. 33.
    Ker K, et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Blommaert D, et al. Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery. J Am Coll Cardiol. 2000;35(6):1411–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Neto VA, et al. Temporary atrial pacing in the prevention of postoperative atrial fibrillation. Pacing Clin Electrophysiol. 2007;30(Suppl 1):S79–83.PubMedCrossRefGoogle Scholar
  36. 36.
    Alpert JS, Petersen P, Godtfredsen J. Atrial fibrillation: natural history, complications, and management. Annu Rev Med. 1988;39:41–52.PubMedCrossRefGoogle Scholar
  37. 37.
    Elmi F, Tullo NG, Khalighi K. Natural history and predictors of temporary epicardial pacemaker wire function in patients after open heart surgery. Cardiology. 2002;98(4):175–80.PubMedCrossRefGoogle Scholar
  38. 38.
    Gordon RS, et al. Permanent cardiac pacing after a cardiac operation: predicting the use of permanent pacemakers. Ann Thorac Surg. 1998;66(5):1698–704.PubMedCrossRefGoogle Scholar
  39. 39.
    Merin O, et al. Permanent pacemaker implantation following cardiac surgery: indications and long-term follow-up. Pacing Clin Electrophysiol. 2009;32(1):7–12.PubMedCrossRefGoogle Scholar
  40. 40.
    Del Nido P, Goldman BS. Temporary epicardial pacing after open heart surgery: complications and prevention. J Card Surg. 1989;4(1):99–103.PubMedCrossRefGoogle Scholar
  41. 41.
    van den Berghe G, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.PubMedCrossRefGoogle Scholar
  42. 42.
    Hajjar LA, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559–67.PubMedCrossRefGoogle Scholar
  43. 43.
    van Straten AH, et al. Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up. Interact Cardiovasc Thorac Surg. 2010;10(1):37–42.PubMedCrossRefGoogle Scholar
  44. 44.
    Hebert PC, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group. N Engl J Med. 1999;340(6):409–17.PubMedCrossRefGoogle Scholar
  45. 45.
    Weitzel NS, et al. Platelet mapping as part of modified thromboelastography (TEG(R)) in patients undergoing cardiac surgery and cardiopulmonary bypass. Anaesthesia. 2012;67(10):1158–65.PubMedCrossRefGoogle Scholar
  46. 46.
    White JM, Ruygrok PN. Intra-aortic balloon counterpulsation in contemporary practice - where are we? Heart Lung Circ. 2015;24(4):335–41.PubMedCrossRefGoogle Scholar
  47. 47.
    Kogan A, et al. Heparin-free management of intra-aortic balloon pump after cardiac surgery. J Card Surg. 2012;27(4):434–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Choong CK, et al. Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes. Eur J Cardiothorac Surg. 2007;31(5):834–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Dunning J, et al. Guideline for resuscitation in cardiac arrest after cardiac surgery. Eur J Cardiothorac Surg. 2009;36(1):3–28.PubMedCrossRefGoogle Scholar
  50. 50.
    Schulman S. Pharmacologic tools to reduce bleeding in surgery. Hematology Am Soc Hematol Educ Program. 2012;2012:517–21.PubMedGoogle Scholar
  51. 51.
    Bolliger D, et al. The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations. Anesth Analg. 2010;111(3):601–8.PubMedCrossRefGoogle Scholar
  52. 52.
    O’Connell KA, et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006;295(3):293–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Carmona P, et al. Management of cardiac tamponade after cardiac surgery. J Cardiothorac Vasc Anesth. 2012;26(2):302–11.PubMedCrossRefGoogle Scholar
  54. 54.
    Pepi M, et al. Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic consequences. Br Heart J. 1994;72(4):327–31.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Tsang TS, Oh JK, Seward JB. Diagnosis and management of cardiac tamponade in the era of echocardiography. Clin Cardiol. 1999;22(7):446–52.PubMedCrossRefGoogle Scholar
  56. 56.
    Price S, et al. 'Tamponade' following cardiac surgery: terminology and echocardiography may both mislead. Eur J Cardiothorac Surg. 2004;26(6):1156–60.PubMedCrossRefGoogle Scholar
  57. 57.
    Vives M, et al. Cardiac surgery-associated acute kidney injury. Interact Cardiovasc Thorac Surg. 2014;18(5):637–45.PubMedCrossRefGoogle Scholar
  58. 58.
    Shin SR, et al. Prediction and prevention of acute kidney injury after cardiac surgery. Biomed Res Int. 2016;2016:2985148.PubMedPubMedCentralGoogle Scholar
  59. 59.
    Dreischulte T, et al. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int. 2015;88(2):396–403.PubMedCrossRefGoogle Scholar
  60. 60.
    Zacharias M, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev. 2013;9:Cd003590.Google Scholar
  61. 61.
    Itagaki S, Hosseinian L, Varghese R. Right ventricular failure after cardiac surgery: management strategies. Semin Thorac Cardiovasc Surg. 2012;24(3):188–94.PubMedCrossRefGoogle Scholar
  62. 62.
    Vlahakes GJ. Right ventricular failure after cardiac surgery. Cardiol Clin. 2012;30(2):283–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Thunberg CA, et al. Pulmonary hypertension in patients undergoing cardiac surgery: pathophysiology, perioperative management, and outcomes. J Cardiothorac Vasc Anesth. 2013;27(3):551–72.PubMedCrossRefGoogle Scholar
  64. 64.
    Zener JC, et al. Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol. 1972;30(8):820–6.PubMedCrossRefGoogle Scholar
  65. 65.
    Denault A, et al. Pulmonary hypertension in cardiac surgery. Curr Cardiol Rev. 2010;6(1):1–14.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Mathew JP, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter study of perioperative ischemia research group. JAMA. 1996;276(4):300–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Mathew JP, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291(14):1720–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Gowda SA, Shah A, Steinberg JS. Cardioversion of atrial fibrillation. Prog Cardiovasc Dis. 2005;48(2):88–107.PubMedCrossRefGoogle Scholar
  69. 69.
    Risius T, et al. Comparison of antero-lateral versus antero-posterior electrode position for biphasic external cardioversion of atrial flutter. Am J Cardiol. 2009;104(11):1547–50.PubMedCrossRefGoogle Scholar
  70. 70.
    Khasnis A, et al. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol. 2005;28(7):710–21.PubMedCrossRefGoogle Scholar
  71. 71.
    Arsenault KA, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2013;1:Cd003611.Google Scholar
  72. 72.
    McDonald MG, Au NT, Rettie AE. P450-based drug-drug interactions of Amiodarone and its metabolites: diversity of inhibitory mechanisms. Drug Metab Dispos. 2015;43(11):1661–9.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Oral H, et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med. 1999;340(24):1849–54.PubMedCrossRefGoogle Scholar
  74. 74.
    Chatterjee S, et al. Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis. Pacing Clin Electrophysiol. 2013;36(8):1017–23.PubMedCrossRefGoogle Scholar
  75. 75.
    Vereckei A. Current algorithms for the diagnosis of wide QRS complex tachycardias. Curr Cardiol Rev. 2014;10(3):262–76.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Califf RM, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31(2):241–51.PubMedCrossRefGoogle Scholar
  77. 77.
    Domanski MJ, et al. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA. 2011;305(6):585–91.PubMedCrossRefGoogle Scholar
  78. 78.
    Hauser AM, et al. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty. J Am Coll Cardiol. 1985;5(2 Pt 1):193–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Lobo DN, Awad S. Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent 'pre-renal' acute kidney injury?: con. Kidney Int. 2014;86(6):1096–105.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    McKhann GM, et al. Stroke and encephalopathy after cardiac surgery: an update. Stroke. 2006;37(2):562–71.PubMedCrossRefGoogle Scholar
  81. 81.
    Wityk RJ, et al. Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol. 2001;58(4):571–6.PubMedCrossRefGoogle Scholar
  82. 82.
    Hartnell GG, et al. Safety of MR imaging in patients who have retained metallic materials after cardiac surgery. AJR Am J Roentgenol. 1997;168(5):1157–9.PubMedCrossRefGoogle Scholar
  83. 83.
    Bush CK, et al. Endovascular treatment with stent-retriever devices for acute ischemic stroke: a meta-analysis of randomized controlled trials. PLoS One. 2016;11(1):e0147287.PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Coull BM, et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the joint stroke guideline development Committee of the American Academy of neurology and the American Stroke Association (a division of the American Heart Association). Stroke. 2002;33(7):1934–42.PubMedCrossRefGoogle Scholar
  85. 85.
    Muth CM, Shank ES. Gas embolism. N Engl J Med. 2000;342(7):476–82.PubMedCrossRefGoogle Scholar
  86. 86.
    Gootjes EC, Wijdicks EF, McClelland RL. Postoperative stupor and coma. Mayo Clin Proc. 2005;80(3):350–4.PubMedCrossRefGoogle Scholar
  87. 87.
    Acher CW, et al. Lexicomp a quantitative assessment of the impact of intercostal artery reimplantation on paralysis risk in thoracoabdominal aortic aneurysm repair. Ann Surg. 2016;248(4):529–40.Google Scholar
  88. 88.
    Coselli JS, et al. Cerebrospinal fluid drainage reduces paraplegia after thoracoabdominal aortic aneurysm repair: results of a randomized clinical trial. J Vasc Surg. 2002;35(4):631–9.PubMedCrossRefGoogle Scholar
  89. 89.
    Ranucci M. Hemostatic and thrombotic issues in cardiac surgery. Semin Thromb Hemost. 2015;41(1):84–90.PubMedCrossRefGoogle Scholar
  90. 90.
    Nader ND, et al. Blood product use in cardiac revascularization: comparison of on- and off-pump techniques. Ann Thorac Surg. 1999;68(5):1640–3.PubMedCrossRefGoogle Scholar
  91. 91.
    Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344(17):1286–92.PubMedCrossRefGoogle Scholar
  92. 92.
    Kerendi F, et al. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery. Ann Thorac Surg. 2007;84(5):1548–53. discussion 1554-5PubMedCrossRefGoogle Scholar
  93. 93.
    Wan C, et al. Clinical presentation, temporal relationship, and outcome in thirty-three patients with type 2 heparin-induced thrombocytopenia after cardiotomy. Ann Thorac Surg. 2006;82(1):21–6.PubMedCrossRefGoogle Scholar
  94. 94.
    Warkentin TE, Sheppard JA. Testing for heparin-induced thrombocytopenia antibodies. Transfus Med Rev. 2006;20(4):259–72.PubMedCrossRefGoogle Scholar
  95. 95.
    Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res. 2006;118(2):165–76.PubMedCrossRefGoogle Scholar
  96. 96.
    Kitamura T, et al. Vascular antispastic medication should take priority over other antihypertensives after coronary artery bypass grafting using a radial artery conduit. Interact Cardiovasc Thorac Surg. 2011;13(6):679–81.PubMedCrossRefGoogle Scholar
  97. 97.
    Kon ZN, et al. Warm ischemia provokes inflammation and regional hypercoagulability within the heart during off-pump coronary artery bypass: a possible target for serine protease inhibition. Eur J Cardiothorac Surg. 2008;33(2):215–21.PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Roger VL, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–e209.PubMedCrossRefGoogle Scholar
  99. 99.
    Yoganathan AP, Woo YR, Sung HW. Turbulent shear stress measurements in the vicinity of aortic heart valve prostheses. J Biomech. 1986;19(6):433–42.PubMedCrossRefGoogle Scholar
  100. 100.
    Matthews IG, et al. In patients undergoing aortic valve replacement, what factors predict the requirement for permanent pacemaker implantation? Interact Cardiovasc Thorac Surg. 2011;12(3):475–9.PubMedCrossRefGoogle Scholar
  101. 101.
    Onalan O, et al. Determinants of pacemaker dependency after coronary and/or mitral or aortic valve surgery with long-term follow-up. Am J Cardiol. 2008;101(2):203–8.PubMedCrossRefGoogle Scholar
  102. 102.
    von Oppell UO, et al. Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy. Eur J Cardiothorac Surg. 2009;35(4):641–50.CrossRefGoogle Scholar
  103. 103.
    Bojar RM, et al. Manual of perioperative Care in Adult Cardiac Surgery the anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations. Anesth Analg. 2011;111(3):601–8.Google Scholar
  104. 104.
    Kaneko T, et al. The safety of deep hypothermic circulatory arrest in aortic valve replacement with unclampable aorta in non-octogenarians. Interact Cardiovasc Thorac Surg. 2015;20(1):79–84.PubMedCrossRefGoogle Scholar
  105. 105.
    Bilal H, et al. Is cerebrospinal fluid drainage of benefit to neuroprotection in patients undergoing surgery on the descending thoracic aorta or thoracoabdominal aorta? Interact Cardiovasc Thorac Surg. 2012;15(4):702–8.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Hernandez AF, et al. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' national cardiac database. Circulation. 2007;116(6):606–12.PubMedCrossRefGoogle Scholar
  107. 107.
    Combes A, et al. Extracorporeal membrane oxygenation for respiratory failure in adults. Curr Opin Crit Care. 2012;18(1):99–104.PubMedCrossRefGoogle Scholar
  108. 108.
    Klima U, et al. Severe right heart failure after heart transplantation. A single-center experience. Transpl Int. 2005;18(3):326–32.PubMedCrossRefGoogle Scholar
  109. 109.
    Al-Dadah AS, et al. Clinical course and predictors of pericardial effusion following cardiac transplantation. Transplant Proc. 2007;39(5):1589–92.PubMedCrossRefGoogle Scholar
  110. 110.
    Davies RR, et al. Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the united network for organ sharing database. J Thorac Cardiovasc Surg. 2010;140(3):700–8. 708.e1-2PubMedCrossRefGoogle Scholar
  111. 111.
    Thajudeen A, et al. Arrhythmias after heart transplantation: mechanisms and management. J Am Heart Assoc. 2012;1(2):e001461.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Andrew S. Kaufman
    • 1
  • Philip S. Mullenix
    • 2
  • Jared L. Antevil
    • 2
  1. 1.General Surgery Resident, Department of SurgeryWalter Reed National Military Medical CenterBethesdaUSA
  2. 2.Division of Cardiothoracic Surgery, Department of SurgeryWalter Reed National Military Medical CenterBethesdaUSA

Personalised recommendations